MAPK3 and central nervous system cancer: Extracellular signal-regulated kinase (ERK)1/2, a downstream target of the RAS/MAPK (mitogen-activated protein kinase) pathway, is reportedly upregulated in glioma and is involved in cell cycle progression, proliferation, and migration [59].